25
Participants
Start Date
March 19, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
December 1, 2030
PIN +anti-PD1
"1. Initial treatment phase:~ PIN injection frequency: day0 and day 3, per 3 weeks for 8 cycles;~ PIN injection dosage:~ Cycle1: 4e9 or 8e9 viral particles of PIN based on the number of injectable lesions, their longest diameter, and the tumor volume capacity .~ Cycle 2\~8: 4e9 or 8e9 viral particles of PIN based on the tumor volume's capacity.~ Anti-PD1: day -3, per 3 weeks for 8 cycles;~2. Maintenance treatment phase:~ No injection lesion: Anti-PD1: day 1, per 3 weeks till 2 years unless PD or serious intolerable AEs.~ Have injection lesion:~ PIN: 4e9 or 8e9 viral particles based on the tumor volume's capacity, per 6 weeks (within first 24 weeks), then per 8 weeks till 2 years unless unavailability of injection lesion, PD or serious intolerable AEs.~ Anti-PD1: day 1, per 3 weeks till 2 years unless PD or serious intolerable AEs.~3. Salvage treatment phase:~Dosage and frequency of administration refer to the initial treatment phase and maintenance treatment phase."
RECRUITING
Biotherapeutic Department of Chinsese PLA Gereral Hospital, Beijing
Collaborators (1)
Changping Laboratory
OTHER
Chinese PLA General Hospital
OTHER